Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Manuka honey dressing is a medical-grade topical wound care product derived from the nectar of the Manuka tree (Leptospermum scoparium). Its primary therapeutic activity is attributed to methylglyoxal (MGO), which provides potent non-peroxide antibacterial properties. It functions by creating a low-pH, high-osmolarity environment that inhibits microbial growth while maintaining a moist wound healing environment. It is used for chronic and acute wounds, including diabetic foot ulcers, pressure ulcers, and surgical wounds, promoting autolytic debridement and reducing inflammation. Medical-grade versions are typically sterilized with gamma radiation to ensure safety for clinical use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on manuka honey dressing.